Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 27 (6), 916-920

Myocardial Tissue Engineering Strategies for Heart Repair: Current State of the Art


Myocardial Tissue Engineering Strategies for Heart Repair: Current State of the Art

Buntaro Fujita et al. Interact Cardiovasc Thorac Surg.


The current state-of-the-art treatment for heart failure patients is aimed at delaying disease progression, relieving symptoms, reducing morbidity and improving survival. Cardiac regeneration of the injured heart, however, is not achieved. Currently, numerous alternative treatment approaches aiming at cardiac regeneration are under investigation. Myocardial tissue engineering strategies follow the idea of in vitro generation of myocardium-like structures for epicardial transplantation. Recently, this field has made tremendous advances regarding in vitro optimization of tissue-engineered constructs, and valuable data have been generated in small animal models. This review summarizes the technical aspects of engineered human myocardium generation, lessons learned from preclinical in vitro and in vivo studies and the current state of this approach on its way to clinical translation.

Similar articles

  • Cellular Cardiomyoplasty and Cardiac Tissue Engineering for Myocardial Therapy
    F Wang et al. Adv Drug Deliv Rev 62 (7-8), 784-97. PMID 20214939. - Review
    Heart diseases, including myocardial infarction (MI) and congestive heart failure (CHF), have high mortality rates. Both MI and CHF are characterized by cardiac muscle da …
  • Myocardial Tissue Engineering for Regenerative Applications
    B Fujita et al. Curr Cardiol Rep 19 (9), 78. PMID 28752277. - Review
    Myocardial tissue engineering technologies have made tremendous advances in recent years. Numerous different strategies are under investigation and have reached different …
  • Cell Sheet Transplantation for Heart Tissue Repair
    K Matsuura et al. J Control Release 169 (3), 336-40. PMID 23500057. - Review
    Cell transplantation is attracting considerable attention as the next-generation therapy for treatment of cardiovascular diseases. We have developed cell sheet engineerin …
  • Engineered Heart Repair
    B Fujita et al. Clin Pharmacol Ther 102 (2), 197-199. PMID 28661033. - Review
    There is a pressing need for the development of advanced heart failure therapeutics. Current state-of-the-art is protection from neurohumoral overstimulation, which fails …
  • Engineering Cardiac Muscle Tissue: A Maturating Field of Research
    F Weinberger et al. Circ Res 120 (9), 1487-1500. PMID 28450366. - Review
    Twenty years after the initial description of a tissue engineered construct, 3-dimensional human cardiac tissues of different kinds are now generated routinely in many la …
See all similar articles

Cited by 1 PubMed Central articles

  • iPSC Bioprinting: Where Are We At?
    S Romanazzo et al. Materials (Basel) 12 (15). PMID 31374871. - Review
    Here, we present a concise review of current 3D bioprinting technologies applied to induced pluripotent stem cells (iPSC). iPSC have recently received a great deal of att …

LinkOut - more resources